Compounding Pharmacies Market Size & Share, by Therapeutic Area (Pain Management, Hormone Replacement Therapy, Dermal Disorders, Nutritional Supplements); Route of Administration (Oral, Topical); Sterility (Non-Sterile Compounding Drugs, Sterile Compounding Drugs) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4762
  • Published Date: Mar 29, 2023
  • Report Format: PDF, PPT

Companies Dominating the Compounding Pharmacies Landscape

top-features-companies
    • B. Braun SE
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pharmacy Technician Certification Board
    • Institutional Pharmacy Solutions, LLC
    • Fagron
    • NewCo Pharma GmbH
    • Triangle Compounding
    • Advance Pharmaceuticals Inc.
    • Athenex, Inc.
    • Dougherty's Pharmacy
    • Nephron Pharmaceuticals Corporation

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • The PTCB Certified Compounded Sterile Preparation Technician (CSPT) Program was introduced by the Pharmacy Technician Certification Board. Since the establishment of the organisation in 1995 and the release of its Certified Pharmacy Technician (CPhT) Program, the PTCB has only offered the CSPTTM Program as a new certification programme. A crucial component in achieving PTCB's aim to promote pharmaceutical safety is the PTCB CSPT Program.

  • The top company in the world for pharmaceutical compounding, Fagron, purchased a 503B outsourcing facility in Boston from Fresenius Kabi. The acquisition included a supply agreement with Fresenius Kabi as well as all operational facets of the facility, including clients, vendors, and about 80 staff. In order to achieve our strategic goal of being the top global platform for sterile outsourced services, this purchase was a crucial step for them.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4762
  • Published Date: Mar 29, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are growing geriatric population, rise in drug failure, surge in prescription for compounded medications, and others.

The market is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2023-2035.

lack of skilled pharmacist, growing restrictions on manufacturing of compounding medication, and lack of consumer preference for compounding drugs are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are B. Braun SE, Pharmacy Technician Certification Board, Institutional Pharmacy Solutions, LLC, Fagron, and more.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by therapeutic area, route of administration, sterility, and by region.

The pain management segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying